Serplulimab Injection

DRUG2 trials

Sponsors

Guangzhou FineImmune Biotechnology Co., LTD.

Conditions

Advanced Solid TumorImmunotherapySerplulimab InjectionTumor Associated Lymph Node T Cell

Phase 1

Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors

RecruitingNCT06302062

Guangzhou FineImmune Biotechnology Co., LTD.Advanced Solid Tumor, Immunotherapy, Tumor Associated Lymph Node T Cell

Start: 2023-06-06End: 2026-06-30Target: 23Updated: 2024-12-03

A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors

RecruitingNCT06716619

Guangzhou FineImmune Biotechnology Co., LTD.Advanced Solid Tumor, Immunotherapy, Serplulimab Injection +1

Start: 2025-02-13End: 2027-12-19Target: 32Updated: 2025-03-26